Ardsley Advisory Partners LP Guardant Health, Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $2.37 Million - $3.31 Million	54,300 Added 49.05%	165,000 $8.88 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $3.19 Million - $8.56 Million	110,700 New	110,700 $4.47 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $19.3 Million - $29 Million	-326,250 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $14.6 Million - $20.4 Million	246,250 Added 307.81%	326,250 $25.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $5.01 Million - $8.82 Million	80,000 New	80,000 $5.11 Million

325

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.